Orders for Sharps Securegard 1mL and 3mL syringes are on the water, introducing a line of competitively priced, low waste,...
– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to work with...
AMSTERDAM, June 17, 2024 /PRNewswire/ -- Monday, at HLTH Europe, the Trustworthy & Responsible AI Network (TRAIN), a consortium of healthcare...
DUBAI, UAE, June 17, 2024 /PRNewswire/ -- XRP Healthcare proudly announces the release of Issue 3 of the highly anticipated...
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71%...
The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people...
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future DALLAS, June 14, 2024 /PRNewswire/ -- Ernst &...
Marcroft Medical proudly announces its launch as a trusted distributor of high-quality medical equipment, offering a comprehensive range of products...
NEW YORK, June 14, 2024 /PRNewswire/ -- The global smart weight, body composition, and BMI scales market size is estimated to grow by...
NEW YORK, June 14, 2024 /PRNewswire/ -- The optometry software market size in North America is estimated to grow by...
LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching...
CHICAGO, June 14, 2024 /PRNewswire/ -- Projected to grow at a CAGR of 10.5%, the global medical equipment maintenance market...
Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen...
Toronto, Ontario--(Newsfile Corp. - June 14, 2024) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")...
Partner’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companiesMINNEAPOLIS, June...
Acquisition expected to be synergistic with FOXO’s epigenetic technology in community health and addiction recovery settings as well as contribute...
24-month overall survival rate of 67 percent achieved with talquetamab 0.8mg/kg biweekly dosing in the Phase 1/2 MonumenTAL-1 study1 BEERSE,...
Home Care 100's June gathering served as a critical platform for advancing dialogue around growth, payer relationships and new technology....
NEW YORK, June 13, 2024 /PRNewswire/ -- The healthcare analytics market size in APAC is estimated to grow by USD 20.84...
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received confirmation...